Effect of muscle selection for botulinum neurotoxin treatment on spasticity in patients with post-stroke elbow flexor muscle over-activity: an observational prospective study.

IF 1.3 4区 医学 Q4 NEUROSCIENCES
Somatosensory and Motor Research Pub Date : 2022-03-01 Epub Date: 2021-10-10 DOI:10.1080/08990220.2021.1986383
İlker Şengül, Ayhan Aşkın, Aliye Tosun
{"title":"Effect of muscle selection for botulinum neurotoxin treatment on spasticity in patients with post-stroke elbow flexor muscle over-activity: an observational prospective study.","authors":"İlker Şengül,&nbsp;Ayhan Aşkın,&nbsp;Aliye Tosun","doi":"10.1080/08990220.2021.1986383","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose/aim: </strong>To investigate the effect of muscle selection for botulinum neurotoxin A (BoNT-A) treatment on spasticity in patients with post-stroke elbow flexor muscle over-activity.</p><p><strong>Materials and methods: </strong>Chronic stroke patients with a deforming spastic paresis in the upper limb (elbow flexion with forearm pronation) who were injected BoNT-A into at least one of elbow flexor muscles (brachialis, brachioradialis, and biceps brachii) were included in this prospective observational study. The main outcome measure was spasticity angle by Tardieu Scale recorded at pre-treatment and week 4 after treatment.</p><p><strong>Results: </strong>Three muscle selection groups with sufficient sample size for statistical analysis were able to be created; brachialis (<i>n</i> = 14), biceps brachii (<i>n</i> = 21), and brachialis plus brachioradialis (<i>n</i> = 11). Although there was a significant improvement in spasticity angle within all groups over time (<i>p</i> < 0.05), the change in spasticity angle was not different between the groups (<i>p</i> > 0.05 for each pairwise comparison). However, the magnitude of the change in spasticity angle was larger in the groups in which brachialis was preferred.</p><p><strong>Conclusions: </strong>In stroke patients with a spontaneous spastic posture of elbow flexion and forearm pronation, targeting brachialis for BoNT-A injection seems more effective in reducing the severity of spasticity.</p><p><strong>Clinical trial registration no: </strong>NCT04036981.</p>","PeriodicalId":49498,"journal":{"name":"Somatosensory and Motor Research","volume":"39 1","pages":"10-17"},"PeriodicalIF":1.3000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Somatosensory and Motor Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08990220.2021.1986383","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/10 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 2

Abstract

Purpose/aim: To investigate the effect of muscle selection for botulinum neurotoxin A (BoNT-A) treatment on spasticity in patients with post-stroke elbow flexor muscle over-activity.

Materials and methods: Chronic stroke patients with a deforming spastic paresis in the upper limb (elbow flexion with forearm pronation) who were injected BoNT-A into at least one of elbow flexor muscles (brachialis, brachioradialis, and biceps brachii) were included in this prospective observational study. The main outcome measure was spasticity angle by Tardieu Scale recorded at pre-treatment and week 4 after treatment.

Results: Three muscle selection groups with sufficient sample size for statistical analysis were able to be created; brachialis (n = 14), biceps brachii (n = 21), and brachialis plus brachioradialis (n = 11). Although there was a significant improvement in spasticity angle within all groups over time (p < 0.05), the change in spasticity angle was not different between the groups (p > 0.05 for each pairwise comparison). However, the magnitude of the change in spasticity angle was larger in the groups in which brachialis was preferred.

Conclusions: In stroke patients with a spontaneous spastic posture of elbow flexion and forearm pronation, targeting brachialis for BoNT-A injection seems more effective in reducing the severity of spasticity.

Clinical trial registration no: NCT04036981.

肉毒杆菌神经毒素治疗对中风后肘屈肌过度活动患者痉挛的影响:一项观察性前瞻性研究。
目的:探讨肉毒杆菌神经毒素A (BoNT-A)治疗中肌肉选择对卒中后肘屈肌过度活动患者痉挛的影响。材料和方法:慢性脑卒中上肢变形性痉挛性轻瘫(肘关节屈曲伴前臂旋前)患者在至少一块肘关节屈肌(肱肌、肱桡肌和肱二头肌)注射BoNT-A,纳入本前瞻性观察性研究。主要观察指标为治疗前和治疗后第4周用Tardieu量表记录的痉挛角。结果:建立了3个样本容量足够进行统计分析的肌肉选择组;肱肌(n = 14),肱二头肌(n = 21),肱肌加肱桡肌(n = 11)。各组痉挛角度随时间的推移均有显著改善(两两比较均p > 0.05)。然而,首选肱肌组痉挛角的变化幅度更大。结论:对于有肘关节屈曲和前臂旋前自发性痉挛姿势的脑卒中患者,针对肱肌注射BoNT-A似乎能更有效地减轻痉挛的严重程度。临床试验注册号:NCT04036981。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Somatosensory and Motor Research
Somatosensory and Motor Research 医学-神经科学
自引率
0.00%
发文量
4
审稿时长
>12 weeks
期刊介绍: Somatosensory & Motor Research publishes original, high-quality papers that encompass the entire range of investigations related to the neural bases for somatic sensation, somatic motor function, somatic motor integration, and modeling thereof. Comprising anatomical, physiological, biochemical, pharmacological, behavioural, and psychophysical studies, Somatosensory & Motor Research covers all facets of the peripheral and central processes underlying cutaneous sensation, and includes studies relating to afferent and efferent mechanisms of deep structures (e.g., viscera, muscle). Studies of motor systems at all levels of the neuraxis are covered, but reports restricted to non-neural aspects of muscle generally would belong in other journals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信